Prostatic Cancer Versus Androgen Deficiency
NCT02235142 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1614
Last updated 2022-01-20
Summary
Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship between the hormonal status and the type of the tumor at the time of surgical intervention as well as follow up of the patients.
Conditions
- Cancer of Prostate
Interventions
- OTHER
-
Blood sample
Sponsors & Collaborators
-
Hopital Foch
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-03
- Primary Completion
- 2016-06-27
- Completion
- 2021-12-22
Countries
- France
- Guadeloupe
- Martinique
Study Locations
More Related Trials
-
Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients
NCT01254513 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trials of Adjuvant Androgen Deprivation in Localized Prostate Cancer
NCT02175212 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer
NCT02440802 ·Status: UNKNOWN
-
A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
NCT02066961 ·Status: COMPLETED
-
A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer
NCT01383863 ·Status: COMPLETED
-
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
NCT00967954 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
NCT00161252 ·Status: WITHDRAWN
-
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
NCT06046131 ·Status: RECRUITING ·Phase: NA
-
Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15
NCT00955435 ·Status: UNKNOWN
-
Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.
NCT01123434 ·Status: COMPLETED
-
Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy
NCT01224405 ·Status: UNKNOWN ·Phase: PHASE3
-
Evaluation of Cardiotoxicity and Hypertension in Patients With Non Metastatic Castration Resistant Prostatic Carcinoma
NCT04567875 ·Status: UNKNOWN
-
Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)
NCT02543255 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer
NCT01957436 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
NCT03516812 ·Status: COMPLETED ·Phase: PHASE2
-
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
NCT00002924 ·Status: COMPLETED
-
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
NCT00455624 ·Status: COMPLETED
-
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
NCT03035500 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT02008058 ·Status: COMPLETED
-
Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer
NCT01530295 ·Status: UNKNOWN ·Phase: NA
-
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
NCT05352178 ·Status: RECRUITING ·Phase: PHASE3
-
Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting
NCT03912883 ·Status: ACTIVE_NOT_RECRUITING
-
LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel
NCT02182622 ·Status: WITHDRAWN ·Phase: PHASE1
-
Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients
NCT06500741 ·Status: COMPLETED
-
Study of Treatment Choice in Patients With Localized Prostate Cancer
NCT01177865 ·Status: UNKNOWN ·Phase: NA